{
    "eid": "2-s2.0-84905992942",
    "title": "Comparative efficacy and safety of different doses of ergocalciferol supplementation in patients with metabolic syndrome",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Pharmacy",
            "@code": "3611"
        },
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Toxicology",
            "@code": "3005"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "Pharmaceutical Science",
            "@code": "3003"
        }
    ],
    "keywords": [
        "25-hydroxyvitamin D",
        "Efficacy",
        "Ergocalciferol",
        "Metabolic syndrome",
        "Safety",
        "Vitamin D"
    ],
    "authors": [
        "Nakarin Sansanayudh"
    ],
    "citedby-count": 11,
    "ref-count": 29,
    "ref-list": [
        "Vitamin D deficiency: A worldwide problem with health consequences",
        "Medical progress: Vitamin D deficiency",
        "Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline",
        null,
        null,
        null,
        null,
        "The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency",
        "Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults",
        "Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol",
        null,
        null,
        null,
        "Srinagarind Med J",
        "Serum 25-hydroxy vitamin D and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans",
        "Relationship between serum vitamin D concentration and metabolic syndrome among Iranian adults population",
        "Association of serum 25-hydroxyvitamin D levels with markers for metabolic syndrome in the elderly: A repeated measure analysis",
        "Thail Heart J",
        "Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials",
        "Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population?",
        "Vitamin D deficiency in patients with Graves' disease: Probably something more than a casual association",
        "Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States.",
        "Hypovitaminosis D is associated with insulin resistance and \u03b2 cell dysfunction",
        "Redefining vitamin D insufficiency",
        "Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement",
        "Design and Analysis of Experiments",
        null,
        "Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004",
        "Decreased bioavailability of vitamin D in obesity"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hilo",
            "affilname": "University of Hawaii at Hilo",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Phramongkutklao College of Medicine",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}